Report Detail

Request for Sample of this report

Pharma & Healthcare Global Human Prostaglandin Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4680895
    • |
  • 26 February, 2026
    • |
  • Global
    • |
  • 87 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Human Prostaglandin market size was valued at US$ 474 million in 2025 and is forecast to a readjusted size of US$ 769 million by 2032 with a CAGR of 7.2% during review period.
Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Human Prostaglandin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Human Prostaglandin market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Human Prostaglandin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Human Prostaglandin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Human Prostaglandin market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Prostaglandin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Prostaglandin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi CEPiA, Kyowa Hakko Pharma, Cayman Chemical, Yonsung Fine Chemicals, Johnson Matthey, Chirogate, Everlight Chemical, ANVI Pharma, AUSUN Pharmaceutical, Aspen Biopharma Labs, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Human Prostaglandin market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
(+)-Cloprostenol issopropylester
Latanoprost
Bimatoprost
Alprostadil
Misoprostol
Dinoprostone
Carboprost
CarboprostMethylate
Others
Market segment by Application
Cardiovascular
Gynecological and Obstetrical
Ophthalmologic
Others
Major players covered
Sanofi CEPiA
Kyowa Hakko Pharma
Cayman Chemical
Yonsung Fine Chemicals
Johnson Matthey
Chirogate
Everlight Chemical
ANVI Pharma
AUSUN Pharmaceutical
Aspen Biopharma Labs
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Prostaglandin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Prostaglandin, with price, sales quantity, revenue, and global market share of Human Prostaglandin from 2021 to 2026.
Chapter 3, the Human Prostaglandin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Prostaglandin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Human Prostaglandin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Prostaglandin.
Chapter 14 and 15, to describe Human Prostaglandin sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Human Prostaglandin Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 (+)-Cloprostenol issopropylester
    • 1.3.3 Latanoprost
    • 1.3.4 Bimatoprost
    • 1.3.5 Alprostadil
    • 1.3.6 Misoprostol
    • 1.3.7 Dinoprostone
    • 1.3.8 Carboprost
    • 1.3.9 CarboprostMethylate
    • 1.3.10 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Human Prostaglandin Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Cardiovascular
    • 1.4.3 Gynecological and Obstetrical
    • 1.4.4 Ophthalmologic
    • 1.4.5 Others
  • 1.5 Global Human Prostaglandin Market Size & Forecast
    • 1.5.1 Global Human Prostaglandin Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Human Prostaglandin Sales Quantity (2021-2032)
    • 1.5.3 Global Human Prostaglandin Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Sanofi CEPiA
    • 2.1.1 Sanofi CEPiA Details
    • 2.1.2 Sanofi CEPiA Major Business
    • 2.1.3 Sanofi CEPiA Human Prostaglandin Product and Services
    • 2.1.4 Sanofi CEPiA Human Prostaglandin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Sanofi CEPiA Recent Developments/Updates
  • 2.2 Kyowa Hakko Pharma
    • 2.2.1 Kyowa Hakko Pharma Details
    • 2.2.2 Kyowa Hakko Pharma Major Business
    • 2.2.3 Kyowa Hakko Pharma Human Prostaglandin Product and Services
    • 2.2.4 Kyowa Hakko Pharma Human Prostaglandin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Kyowa Hakko Pharma Recent Developments/Updates
  • 2.3 Cayman Chemical
    • 2.3.1 Cayman Chemical Details
    • 2.3.2 Cayman Chemical Major Business
    • 2.3.3 Cayman Chemical Human Prostaglandin Product and Services
    • 2.3.4 Cayman Chemical Human Prostaglandin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Cayman Chemical Recent Developments/Updates
  • 2.4 Yonsung Fine Chemicals
    • 2.4.1 Yonsung Fine Chemicals Details
    • 2.4.2 Yonsung Fine Chemicals Major Business
    • 2.4.3 Yonsung Fine Chemicals Human Prostaglandin Product and Services
    • 2.4.4 Yonsung Fine Chemicals Human Prostaglandin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Yonsung Fine Chemicals Recent Developments/Updates
  • 2.5 Johnson Matthey
    • 2.5.1 Johnson Matthey Details
    • 2.5.2 Johnson Matthey Major Business
    • 2.5.3 Johnson Matthey Human Prostaglandin Product and Services
    • 2.5.4 Johnson Matthey Human Prostaglandin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Johnson Matthey Recent Developments/Updates
  • 2.6 Chirogate
    • 2.6.1 Chirogate Details
    • 2.6.2 Chirogate Major Business
    • 2.6.3 Chirogate Human Prostaglandin Product and Services
    • 2.6.4 Chirogate Human Prostaglandin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Chirogate Recent Developments/Updates
  • 2.7 Everlight Chemical
    • 2.7.1 Everlight Chemical Details
    • 2.7.2 Everlight Chemical Major Business
    • 2.7.3 Everlight Chemical Human Prostaglandin Product and Services
    • 2.7.4 Everlight Chemical Human Prostaglandin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Everlight Chemical Recent Developments/Updates
  • 2.8 ANVI Pharma
    • 2.8.1 ANVI Pharma Details
    • 2.8.2 ANVI Pharma Major Business
    • 2.8.3 ANVI Pharma Human Prostaglandin Product and Services
    • 2.8.4 ANVI Pharma Human Prostaglandin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 ANVI Pharma Recent Developments/Updates
  • 2.9 AUSUN Pharmaceutical
    • 2.9.1 AUSUN Pharmaceutical Details
    • 2.9.2 AUSUN Pharmaceutical Major Business
    • 2.9.3 AUSUN Pharmaceutical Human Prostaglandin Product and Services
    • 2.9.4 AUSUN Pharmaceutical Human Prostaglandin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 AUSUN Pharmaceutical Recent Developments/Updates
  • 2.10 Aspen Biopharma Labs
    • 2.10.1 Aspen Biopharma Labs Details
    • 2.10.2 Aspen Biopharma Labs Major Business
    • 2.10.3 Aspen Biopharma Labs Human Prostaglandin Product and Services
    • 2.10.4 Aspen Biopharma Labs Human Prostaglandin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Aspen Biopharma Labs Recent Developments/Updates

3 Competitive Environment: Human Prostaglandin by Manufacturer

  • 3.1 Global Human Prostaglandin Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Human Prostaglandin Revenue by Manufacturer (2021-2026)
  • 3.3 Global Human Prostaglandin Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Human Prostaglandin by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Human Prostaglandin Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Human Prostaglandin Manufacturer Market Share in 2025
  • 3.5 Human Prostaglandin Market: Overall Company Footprint Analysis
    • 3.5.1 Human Prostaglandin Market: Region Footprint
    • 3.5.2 Human Prostaglandin Market: Company Product Type Footprint
    • 3.5.3 Human Prostaglandin Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Human Prostaglandin Market Size by Region
    • 4.1.1 Global Human Prostaglandin Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Human Prostaglandin Consumption Value by Region (2021-2032)
    • 4.1.3 Global Human Prostaglandin Average Price by Region (2021-2032)
  • 4.2 North America Human Prostaglandin Consumption Value (2021-2032)
  • 4.3 Europe Human Prostaglandin Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Human Prostaglandin Consumption Value (2021-2032)
  • 4.5 South America Human Prostaglandin Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Human Prostaglandin Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Human Prostaglandin Sales Quantity by Type (2021-2032)
  • 5.2 Global Human Prostaglandin Consumption Value by Type (2021-2032)
  • 5.3 Global Human Prostaglandin Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Human Prostaglandin Sales Quantity by Application (2021-2032)
  • 6.2 Global Human Prostaglandin Consumption Value by Application (2021-2032)
  • 6.3 Global Human Prostaglandin Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Human Prostaglandin Sales Quantity by Type (2021-2032)
  • 7.2 North America Human Prostaglandin Sales Quantity by Application (2021-2032)
  • 7.3 North America Human Prostaglandin Market Size by Country
    • 7.3.1 North America Human Prostaglandin Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Human Prostaglandin Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Human Prostaglandin Sales Quantity by Type (2021-2032)
  • 8.2 Europe Human Prostaglandin Sales Quantity by Application (2021-2032)
  • 8.3 Europe Human Prostaglandin Market Size by Country
    • 8.3.1 Europe Human Prostaglandin Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Human Prostaglandin Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Human Prostaglandin Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Human Prostaglandin Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Human Prostaglandin Market Size by Region
    • 9.3.1 Asia-Pacific Human Prostaglandin Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Human Prostaglandin Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Human Prostaglandin Sales Quantity by Type (2021-2032)
  • 10.2 South America Human Prostaglandin Sales Quantity by Application (2021-2032)
  • 10.3 South America Human Prostaglandin Market Size by Country
    • 10.3.1 South America Human Prostaglandin Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Human Prostaglandin Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Human Prostaglandin Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Human Prostaglandin Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Human Prostaglandin Market Size by Country
    • 11.3.1 Middle East & Africa Human Prostaglandin Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Human Prostaglandin Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Human Prostaglandin Market Drivers
  • 12.2 Human Prostaglandin Market Restraints
  • 12.3 Human Prostaglandin Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Human Prostaglandin and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Human Prostaglandin
  • 13.3 Human Prostaglandin Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Human Prostaglandin Typical Distributors
  • 14.3 Human Prostaglandin Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Human Prostaglandin. Industry analysis & Market Report on Human Prostaglandin is a syndicated market report, published as Global Human Prostaglandin Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Human Prostaglandin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo